Key facts
- This page summarizes Ray Aspiri's Form 4 filing for OMEROS CORP (OMER).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 14 Feb 2022, 16:05.
Ray Aspiri - 11 Jun 2021 Form 4 Insider Report for OMEROS CORP (OMER)
- Reporting relationship
- Director
- Issuer ticker
- OMER
- Reported as of
- 11 Jun 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Peter B. Cancelmo, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Ray Aspiri filed Form 4 for OMEROS CORP (OMER) on 14 Feb 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OMER
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +7,500
- Change %
- Price
- $0.000000
- Shares after
- 7,500
- Date
- 11 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $15.81
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Ray Aspiri is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 11, 2021.
Footnote F2
The stock option reported on this Form 4 was scheduled to vest on the day before the date of the issuer's 2022 annual meeting of the shareholders, provided that the reporting person continued to serve as a director of the issuer through such date. The reporting person retired from the issuer's board of directors in October 2021. As a result, the option was terminated without becoming exercisable.